RATIONALE: Reactivation tuberculosis (TB) occurs as a result of reactivation of latent TB infection (LTBI), and was reported to occur in the United States at a rate of 0.10 to 0.16 cases per 100 person-years in the 1950s; it has not been measured since. OBJECTIVES: To calculate the rate of reactivation TB in a U.S. community. METHODS: A population-based tuberculin skin test survey for LTBI was performed in western Palm Beach County, Florida, from 1998 to 2000 along with a cluster analysis of TB case isolates in the same area from 1997 to 2001. Reactivation (unclustered) TB was presumed to have arisen from the population with LTBI. MEASUREMENTS AND MAIN RESULTS: The rate of reactivation TB among persons with LTBI without HIV infection was 0.040 cases per 100 person-years (95% confidence interval [CI], 0.024-0.067) using the n method and 0.058 cases per 100 person-years (95% CI, 0.038-0.089) using the n-1 method. HIV infection was the strongest risk factor for reactivation (rate ratio [RR], 57; 95% CI, 27-120; P < 0.001). Among persons without HIV infection, reactivation was increased among those older than 50 years (RR, 3.8; 95% CI, 1.3-11) and among those born in the United States (RR, 3.2; 95% CI, 1.1-9.3). CONCLUSIONS: Rates of reactivation TB in this area have declined substantially since the 1950s. The greatest part of this decline may be attributed to the disappearance of old, healed TB in the population. If similar declines are seen in other areas of the United States, the cost-effectiveness of screening and treatment of LTBI may be substantially less than previously estimated.
RATIONALE: Reactivation tuberculosis (TB) occurs as a result of reactivation of latent TB infection (LTBI), and was reported to occur in the United States at a rate of 0.10 to 0.16 cases per 100 person-years in the 1950s; it has not been measured since. OBJECTIVES: To calculate the rate of reactivation TB in a U.S. community. METHODS: A population-based tuberculin skin test survey for LTBI was performed in western Palm Beach County, Florida, from 1998 to 2000 along with a cluster analysis of TB case isolates in the same area from 1997 to 2001. Reactivation (unclustered) TB was presumed to have arisen from the population with LTBI. MEASUREMENTS AND MAIN RESULTS: The rate of reactivation TB among persons with LTBI without HIV infection was 0.040 cases per 100 person-years (95% confidence interval [CI], 0.024-0.067) using the n method and 0.058 cases per 100 person-years (95% CI, 0.038-0.089) using the n-1 method. HIV infection was the strongest risk factor for reactivation (rate ratio [RR], 57; 95% CI, 27-120; P < 0.001). Among persons without HIV infection, reactivation was increased among those older than 50 years (RR, 3.8; 95% CI, 1.3-11) and among those born in the United States (RR, 3.2; 95% CI, 1.1-9.3). CONCLUSIONS: Rates of reactivation TB in this area have declined substantially since the 1950s. The greatest part of this decline may be attributed to the disappearance of old, healed TB in the population. If similar declines are seen in other areas of the United States, the cost-effectiveness of screening and treatment of LTBI may be substantially less than previously estimated.
Authors: J R Glynn; J Bauer; A S de Boer; M W Borgdorff; P E Fine; P Godfrey-Faussett; E Vynnycky Journal: Int J Tuberc Lung Dis Date: 1999-12 Impact factor: 2.373
Authors: Elvin Geng; Barry Kreiswirth; Cynthia Driver; Jiehui Li; Joseph Burzynski; Phyllis DellaLatta; Angel LaPaz; Neil W Schluger Journal: N Engl J Med Date: 2002-05-09 Impact factor: 91.245
Authors: Carrie Reed; C Fordham von Reyn; Sandra Chamblee; Tedd V Ellerbrock; Johnny W Johnson; Bryan J Marsh; Linda S Johnson; Robert J Trenschel; C Robert Horsburgh Journal: Am J Epidemiol Date: 2006-05-04 Impact factor: 4.897
Authors: Dale Stratford; Sandra Chamblee; Tedd V Ellerbrock; Rev Johnny W Johnson; Denny Abbott; C Fordham Reyn; C Robert Horsburgh Journal: J Gen Intern Med Date: 2003-07 Impact factor: 5.128
Authors: Amanda Y Sun; Madhukar Pai; Henrik Salje; Srinath Satyanarayana; Sarang Deo; David W Dowdy Journal: Am J Epidemiol Date: 2013-10-07 Impact factor: 4.897
Authors: David W Dowdy; Jonathan E Golub; Valeria Saraceni; Lawrence H Moulton; Solange C Cavalcante; Silvia Cohn; Antonio G Pacheco; Richard E Chaisson; Betina Durovni Journal: J Acquir Immune Defic Syndr Date: 2014-08-15 Impact factor: 3.731
Authors: Francesca Barletta; Larissa Otero; Bouke C de Jong; Tomotada Iwamoto; Kentaro Arikawa; Patrick Van der Stuyft; Stefan Niemann; Matthias Merker; Cécile Uwizeye; Carlos Seas; Leen Rigouts Journal: J Clin Microbiol Date: 2015-03-25 Impact factor: 5.948
Authors: Benjamin P Linas; Angela Y Wong; Kenneth A Freedberg; C Robert Horsburgh Journal: Am J Respir Crit Care Med Date: 2011-09-01 Impact factor: 21.405
Authors: Giorgio Guzzetta; Marco Ajelli; Zhenhua Yang; Leonard N Mukasa; Naveen Patil; Joseph H Bates; Denise E Kirschner; Stefano Merler Journal: J Theor Biol Date: 2015-06-05 Impact factor: 2.691
Authors: Rita M Zorzenon dos Santos; Ana Amador; Wayner V de Souza; Maria Fatima P M de Albuquerque; Silvina Ponce Dawson; Antonio Ruffino-Netto; Carlos R Zárate-Bladés; Celio L Silva Journal: PLoS One Date: 2010-11-30 Impact factor: 3.240